Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP324888.RAdJHGXA7RUWgw44otwj_9AvidJL_4UdbyAnrzdaAo8CQ130_assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324888.RAdJHGXA7RUWgw44otwj_9AvidJL_4UdbyAnrzdaAo8CQ130_provenance.
• NP325046.RAb3ZbueAdFZEzC-gfn7DFNNdsK1OjpfPRrXR3ZuH56wY130_assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325046.RAb3ZbueAdFZEzC-gfn7DFNNdsK1OjpfPRrXR3ZuH56wY130_provenance.
• NP839374.RAYF9KU0Z6b4Sj9uoToJFx58kjdjeZZMkMB2V3OnqaWbA130_assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP839374.RAYF9KU0Z6b4Sj9uoToJFx58kjdjeZZMkMB2V3OnqaWbA130_provenance.
• NP839564.RATZE-Ayb-_kB5nWrjsBkDRoVUTZVhlKkwyz6y85vgRI0130_assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP839564.RATZE-Ayb-_kB5nWrjsBkDRoVUTZVhlKkwyz6y85vgRI0130_provenance.
• NP934446.RAv7olZZbO6FPNZUi_UfUK-_7gtX9d5AthURcK2LMJNw0130_assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP934446.RAv7olZZbO6FPNZUi_UfUK-_7gtX9d5AthURcK2LMJNw0130_provenance.
• NP1359251.RAYoj4qO3rPyLhVFCTaX1E_JCS7xXYZCIwXJx5li5TiU0130_assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1359251.RAYoj4qO3rPyLhVFCTaX1E_JCS7xXYZCIwXJx5li5TiU0130_provenance.
• NP1359252.RAcsbJuJVgQYzyaSF17uD0GJcoakhTL6scZbn7P2VC554130_assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1359252.RAcsbJuJVgQYzyaSF17uD0GJcoakhTL6scZbn7P2VC554130_provenance.
• NP1359256.RAfLCBYiOXFTvUbuKNgJXGlSc3vOCRXPXPS83fVT3nRMs130_assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1359256.RAfLCBYiOXFTvUbuKNgJXGlSc3vOCRXPXPS83fVT3nRMs130_provenance.
• NP1359258.RAbS_XpDUVD2LPwdlj0sirFiKI3s8Iaz-iSVbVub9dSgM130_assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1359258.RAbS_XpDUVD2LPwdlj0sirFiKI3s8Iaz-iSVbVub9dSgM130_provenance.
• NP934428.RAFqUozf2LQxIEjx_aPEqIE20HLY9PlfsFUuOK8b4tAdE130_assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP934428.RAFqUozf2LQxIEjx_aPEqIE20HLY9PlfsFUuOK8b4tAdE130_provenance.
• NP1359253.RAMjUSirDlGdUmnu_qr3O55zzS5Gre7e-el3N2K4ezR8E130_assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1359253.RAMjUSirDlGdUmnu_qr3O55zzS5Gre7e-el3N2K4ezR8E130_provenance.
• NP1359255.RAEaz55375piMYQpbtnnlprA6RfXvcAXYSYsubEbY-HEo130_assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1359255.RAEaz55375piMYQpbtnnlprA6RfXvcAXYSYsubEbY-HEo130_provenance.
• NP1359259.RAPmLFequaITu4TwDrsRSz6PGr6DT2hPG3IQhugEd0i1c130_assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1359259.RAPmLFequaITu4TwDrsRSz6PGr6DT2hPG3IQhugEd0i1c130_provenance.
• NP1359254.RA2jwUOgBusCi1NQ2OzExWYEsii-pnS69qgQktw7iHiok130_assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1359254.RA2jwUOgBusCi1NQ2OzExWYEsii-pnS69qgQktw7iHiok130_provenance.
• NP1359257.RA6DhheOFI78qjETjPWqGVIjutzEEmm329UQcZoV1NfJY130_assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1359257.RA6DhheOFI78qjETjPWqGVIjutzEEmm329UQcZoV1NfJY130_provenance.
• NP1359260.RAyd_DQ4bWUJ6gGixADdx7iMGF3SnG2DnFt9sXJrj5Frg130_assertion description "[Evidence is presented from multiple assay systems including 1) ligand binding to estrogen receptor in a competitive binding assay, 2) ligand ability to induce estrogen receptor binding to DNA, 3) ligand regulation of gene expression from a transfected exogenous (ERE-tk-CAT) or an endogenous (pS2) estrogen-regulated gene, 4) ligand regulation of cell growth in estrogen-dependent human breast cancer cell lines MCF7 and ZR-75-1, and 5) ligand activity in the immature mouse uterine weight bioassay in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1359260.RAyd_DQ4bWUJ6gGixADdx7iMGF3SnG2DnFt9sXJrj5Frg130_provenance.